Latest News

Australian researchers identify new drug target for inflammatory lung disease July 5, 2022

Australian researchers have identified a new drug target for the treatment and prevention of chronic obstructive pulmonary disease.

Is this what health technology assessment has become in Australia? July 5, 2022

Increased costs from earlier treatment and other interventions are a natural consequence of screening more rapid diagnosis. They are the reason for screening and not the reason not to.

TGA authorises government campaign promoting COVID-19 treatments July 4, 2022

The TGA has laid the groundwork for the federal government's $11 million campaign by authorising its promotion of antiviral treatments for COVID-19.

Pre-Budget spending rules not quite that strict after all July 4, 2022

The diabetes decision and potentially Friday's confirmation of 1 July PBS listings suggest some election commitments have been prioritised over others and that the claimed strict spending rules are not that strict after all.

The health system review that is not even being led by health July 4, 2022

Do history and the experience of previous ministers suggest this review might reflect the desire of central agencies to gain control of health policy?

Few should expect 'ministerial discretion' and few should actually apply July 4, 2022

The federal parliament endorsed the enabling legislation last year with no debate or real scrutiny despite public recognition of 'unintended consequences' in the form of undesirable delistings of PBS-listed medicines.

Novartis considers spin-out of Sandoz off-patent division July 4, 2022

The company has previously announced a strategic review of the division that currently generates around US$10 billion in annual revenue.

Lung cancer screening would save lives but too expensive July 3, 2022

The committee did not recommend even a limited and narrowly targeted screening program despite saying it would reduce deaths from lung cancer.

Over 1,000 medicines facing 'catch-up' reductions in April July 1, 2022

Companies will be closely examining the just published the list of over 1,000 PBS-listed medicines that will be the subject of catch-up price reductions on 1 April next year.

The 'Halton review' likely to be the first of many on pandemic performance July 1, 2022

There are obvious implications from health minister Mark Butler's decision to order a review into Australia's current COVID-19 vaccine and therapeutic procurement arrangements.

Bayer secures new PBS listing and Medicare funded diagnostic July 1, 2022

Australian children now have reimbursed access to a medicine and matching genetic test that enables the underlying cause of multiple NTRK gene fusion cancers to be treated.

AbbVie delivers in its annual 'Month of Possibilities' volunteering event July 1, 2022

After a two-year pandemic-driven hiatus AbbVie has completed its 'Month of Possibilities' annual volunteering event that saw over 170 employees participate in community-focused activities.

Latest Video

Most Read

Pre-Budget spending rules not quite that strict after all

Few should expect 'ministerial discretion' and few should actually apply

Is this what health technology assessment has become in Australia?

The health system review that is not even being led by health

Lung cancer screening would save lives but too expensive

New Stories

Australian researchers identify new drug target for inflammatory lung disease

Is this what health technology assessment has become in Australia?

TGA authorises government campaign promoting COVID-19 treatments

Pre-Budget spending rules not quite that strict after all

The health system review that is not even being led by health

Few should expect 'ministerial discretion' and few should actually apply

Novartis considers spin-out of Sandoz off-patent division

Sign In

Latest Video

Most Read

Pre-Budget spending rules not quite that strict after all

Few should expect 'ministerial discretion' and few should actually apply

Is this what health technology assessment has become in Australia?

The health system review that is not even being led by health

Lung cancer screening would save lives but too expensive

Follow Us

New Stories

Australian researchers identify new drug target for inflammatory lung disease

Is this what health technology assessment has become in Australia?

TGA authorises government campaign promoting COVID-19 treatments

Pre-Budget spending rules not quite that strict after all

The health system review that is not even being led by health

Few should expect 'ministerial discretion' and few should actually apply

Novartis considers spin-out of Sandoz off-patent division